Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease

被引：4
|
作者：
Han, Jin [1 ,2 ,3 ]
Holden, Christopher C. [4 ]
Ahluwalia, Aneet Y. [4 ]
Molokie, Robert E. [2 ,5 ]
Gowhari, Michel [2 ]
Sweiss, Karen [1 ,2 ]
Patel, Pritesh R. [2 ]
Gordeuk, Victor R. [2 ]
Rondelli, Damiano [2 ]
Saraf, Santosh L. [2 ]
机构：
[1] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA
[2] Univ Illinois, Dept Med, Div Hematol Oncol, Chicago, IL 60607 USA
[3] Univ Illinois, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA
[4] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA
[5] Jesse Brown VA Med Ctr, Dept Med, Chicago, IL USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 191卷 / 03期
关键词：
sickle cell disease; transplantation; opioid;
D O I：
10.1111/bjh.16999
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E70 / E72
页数：3
相关论文
共 50 条
  • [1] Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease
    Woodard, P
    Helton, KJ
    Khan, RB
    Hale, GA
    Phipps, S
    Wang, W
    Handgretinger, R
    Cunningham, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (04) : 550 - 552
  • [2] Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches
    Arnold, Staci D.
    Bhatia, Monica
    Horan, John
    Krishnamurti, Lakshmanan
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (04) : 515 - 525
  • [3] Stem cell transplantation after reduced-intensity conditioning for sickle cell disease
    Matthes-Martin, Susanne
    Lawitschka, Anita
    Fritsch, Gerhard
    Lion, Thomas
    Grimm, Brigitte
    Breuer, Sabine
    Boztug, Heidrun
    Karlhuber, Susanne
    Holter, Wolfgang
    Peters, Christina
    Minkov, Milen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (04) : 308 - 312
  • [4] Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome
    C Brachet
    N Azzi
    A Demulder
    C Devalck
    A Gourdin
    B Gulbis
    A Klein
    P Q Le
    M Loop
    E Sariban
    A Ferster
    Bone Marrow Transplantation, 2004, 33 : 799 - 803
  • [5] Haematopoietic stem cell transplantation in children with sickle cell disease: Still to do?
    Peters, Christina
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (01) : 22 - 23
  • [6] Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome
    Brachet, C
    Azzi, N
    Demulder, A
    Devalck, C
    Gourdin, A
    Gulbis, B
    Klein, A
    Le, PQ
    Loop, M
    Sariban, E
    Ferster, A
    BONE MARROW TRANSPLANTATION, 2004, 33 (08) : 799 - 803
  • [7] Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant
    Darbari, Deepika S.
    Liljencrantz, Jaquette
    Ikechi, Austin
    Martin, Staci
    Roderick, Marie Claire
    Fitzhugh, Courtney D.
    Tisdale, John F.
    Thein, Swee Lay
    Hsieh, Matthew
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) : 690 - 693
  • [8] Transcranial Doppler sonography and the effect of haematopoietic stem cell transplantation in sickle cell disease
    Thurn, Sylvia
    Kleinschmidt, Katharina
    Kovacic, Irena
    Wendl, Christina
    Linker, Ralf A.
    Corbacioglu, Selim
    Schlachetzki, Felix
    NEUROLOGICAL RESEARCH AND PRACTICE, 2022, 4 (01):
  • [9] Haematopoietic cell transplantation in the treatment of sickle cell disease
    Atkins, RC
    Walters, MC
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (08) : 1215 - 1224
  • [10] Treatment for sickle cell disease in Africa: should we invest in haematopoietic stem cell transplantation?
    Pule, Gift
    Wonkam, Ambroise
    PAN AFRICAN MEDICAL JOURNAL, 2014, 18
12345